142 related articles for article (PubMed ID: 11149746)
1. TBI, etoposide and cyclophosphamide as a promising conditioning regimen for BMT in childhood ALL in second remission.
Biagi E; Rovelli A; Balduzzi A; De Lorenzo P; Tagliabue A; Uderzo C
Bone Marrow Transplant; 2000 Dec; 26(11):1260-2. PubMed ID: 11149746
[No Abstract] [Full Text] [Related]
2. A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission.
Marks DI; Forman SJ; Blume KG; Pérez WS; Weisdorf DJ; Keating A; Gale RP; Cairo MS; Copelan EA; Horan JT; Lazarus HM; Litzow MR; McCarthy PL; Schultz KR; Smith DD; Trigg ME; Zhang MJ; Horowitz MM
Biol Blood Marrow Transplant; 2006 Apr; 12(4):438-53. PubMed ID: 16545728
[TBL] [Abstract][Full Text] [Related]
3. Conditioning regimens for acute lymphoblastic leukaemia allografts.
Marks DI
Bone Marrow Transplant; 2007 Mar; 39(6):377; author reply 378. PubMed ID: 17277787
[No Abstract] [Full Text] [Related]
4. High-risk acute lymphoblastic leukemia (ALL): is there an alternative approach for increasing the number of cures?
Carella AM
Haematologica; 1992; 77(4):348-51. PubMed ID: 1358772
[No Abstract] [Full Text] [Related]
5. Comparative outcome of hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia following cyclophosphamide and total body irradiation or VP16 and total body irradiation conditioning regimens.
Gassas A; Sung L; Saunders EF; Doyle JJ
Bone Marrow Transplant; 2006 Dec; 38(11):739-43. PubMed ID: 17013424
[TBL] [Abstract][Full Text] [Related]
6. [Changes of thyroid and adrenocortical functions after bone marrow transplantation with MAC conditioning regimen in leukemia patients].
Ma Y; Qiao Z; Yang L
Zhonghua Xue Ye Xue Za Zhi; 1998 Aug; 19(8):402-4. PubMed ID: 11189505
[TBL] [Abstract][Full Text] [Related]
7. High-dose cytosine arabinoside and etoposide with total body irradiation as a preparatory regimen for allogeneic hematopoietic stem-cell transplantation in patients with acute lymphoblastic leukemia.
Sato N; Furukawa T; Kuroha T; Hashimoto S; Masuko M; Takahashi H; Yano T; Abe T; Fuse I; Koike T; Kishi K; Aizawa Y
Bone Marrow Transplant; 2004 Aug; 34(4):299-303. PubMed ID: 15195078
[TBL] [Abstract][Full Text] [Related]
8. A preparatory regimen of total body irradiation, busulphan and melphalan for allogeneic bone marrow transplantation in childhood high-risk leukemia and lymphoma.
Yoshihara T; Naya M; Tsunamoto K; Hojo M; Hibi S; Morimoto A; Todo S; Imashuku S
Anticancer Res; 2003; 23(2C):1739-42. PubMed ID: 12820450
[TBL] [Abstract][Full Text] [Related]
9. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
[TBL] [Abstract][Full Text] [Related]
10. Busulfan and cyclophosphamide as conditioning regimen for autologous BMT in acute lymphoblastic leukemia.
Porcellini A; Manna A; Moretti L; Carotenuto M; Greco MM; Bodenizza C
Bone Marrow Transplant; 1989 May; 4(3):331-3. PubMed ID: 2659120
[No Abstract] [Full Text] [Related]
11. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
[TBL] [Abstract][Full Text] [Related]
12. Can busulfan replace fractionated total body irradiation as conditioning regimen for allogeneic bone marrow transplantation in children with acute lymphoblastic leukemia.
Wachowiak J; Bettoni C; Lange A; Malicki J; Kaczmarek-Kanold M; Głuszak B; Suchnicki K; Daszkiewicz P; Ebell W
Acta Haematol Pol; 1995; 26(4):377-84. PubMed ID: 8571739
[TBL] [Abstract][Full Text] [Related]
13. Idarubicin plus ARA-C followed by allogeneic or autologous bone marrow transplantation in advanced acute lymphoblastic leukemia.
Arcese W; Meloni G; Giona F; Vegna ML; Testi AM; Annino L; Iori AP; Carotenuto M; Resegotti L; Madon E
Bone Marrow Transplant; 1991; 7 Suppl 2():38. PubMed ID: 1878711
[No Abstract] [Full Text] [Related]
14. Successful bone marrow transplant for a patient with T-lymphoblastic lymphoma in second remission preconditioned by total-body irradiation plus melphalan and etoposide.
Nomura N; Uchida H; Nakamura H; Shirota T; Sakai N; Ito H; Suzuki A; Otaka M; Kimura Y; Toyama K
Transplant Proc; 1994 Aug; 26(4):2347. PubMed ID: 8066769
[No Abstract] [Full Text] [Related]
15. Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study.
Bunin N; Aplenc R; Kamani N; Shaw K; Cnaan A; Simms S
Bone Marrow Transplant; 2003 Sep; 32(6):543-8. PubMed ID: 12953124
[TBL] [Abstract][Full Text] [Related]
16. Comparison of haematological recovery kinetics after myeloablative therapy between sibling allogeneic bone marrow and peripheral blood progenitor cell transplantation in the same adult acute lymphoblastic leukaemia patient.
Stockschläder M; Hassan HT; Krüger W; Kabisch H; Zander A
Leuk Res; 1996; 20(11-12):993-6. PubMed ID: 9009260
[No Abstract] [Full Text] [Related]
17. Busulfan and cyclophosphamide as a conditioning regimen for pediatric acute lymphoblastic leukemia patients undergoing bone marrow transplantation.
Shah AJ; Lenarsky C; Kapoor N; Crooks GM; Kohn DB; Parkman R; Epport K; Wilson K; Weinberg K
J Pediatr Hematol Oncol; 2004 Feb; 26(2):91-7. PubMed ID: 14767194
[TBL] [Abstract][Full Text] [Related]
18. Busulphan, cyclophosphamide, and melphalan as conditioning therapy in allogeneic bone marrow transplants for acute lymphoblastic leukemia.
Russell S; Vowels M
Transplant Proc; 1992 Feb; 24(1):183. PubMed ID: 1539236
[No Abstract] [Full Text] [Related]
19. High-dose etoposide in allogeneic stem cell transplantation.
Bruserud O; Reikvam H; Kittang AO; Ahmed AB; Tvedt TH; Sjo M; Hatfield KJ
Cancer Chemother Pharmacol; 2012 Dec; 70(6):765-82. PubMed ID: 23053272
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow transplantation for advanced acute lymphoblastic leukemia in young people: a comparison of two conditioning regimens.
Graham-Pole J; Elfenbein G; Gross S; Higby D; Marcus R; O'Leary M; Weiner R
Bone Marrow Transplant; 1987 Jun; 2(1):85-9. PubMed ID: 3332160
[No Abstract] [Full Text] [Related]
[Next] [New Search]
